Wai Chun Bio-Technology Limited announced that, following the resignation of a previous Company Secretary and Authorised Representative on 19 December 2024, Ms. He Xiaoping has been appointed to both roles with effect from 5 March 2026. According to the announcement, Ms. He assumes these positions under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

Ms. He brings over 13 years of experience in auditing, financial management, company secretarial work, investment, and financing, having worked at leading accounting firms and various listed companies in Hong Kong. She is also a member of the Hong Kong Institute of Certified Public Accountants and holds a degree from the University of Electronic Science and Technology of China.

The board of directors noted that Ms. He is well-equipped to fulfill the responsibilities associated with her new role. As of the date of the announcement, the board comprises one executive director, Mr. Lam Ka Chun, and three independent non-executive directors, Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.